Last summer, Philips Respironics recalled millions of breathing devices, including ventilators, BiPAP and CPAP machines, citing a foam breakdown that can be accidentally inhaled. The FDA later labeled the recall with a class 1 sticker — the most serious type of recall because of the possibility of “death or serious injury” — and has reported 124 deaths “associated with the PE-PUR foam breakdown or suspected foam breakdown” since April 30.
People such as Rochester, N.Y., resident Diane Coleman have continued to use their machines: “It’s not like I can stop using it,” she told the LA Times.
A Philips spokesperson said repairing and replacing the recalled products will continue through “the end of 2022,” the LA Times reported.
Read the full article here.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
